Trials / Recruiting
RecruitingNCT07076979
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric：MetBio-GC
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Shanghai Minimally Invasive Surgery Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This prospective clinical observational study aims to construct a metabolite database specifically for gastric cancer patients using metabolomics technology. It seeks to develop and validate metabolic biomarkers for early diagnosis, prognosis, and prediction of recurrence and metastasis in gastric cancer, thereby a establishing safe, convenient, and highly sensitive method for early screening and prognostic prediction.
Conditions
Timeline
- Start date
- 2025-06-15
- Primary completion
- 2028-07-01
- Completion
- 2030-07-01
- First posted
- 2025-07-22
- Last updated
- 2025-07-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07076979. Inclusion in this directory is not an endorsement.